Patel, Keyur |
NAVIGATE, NCT04365868: Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis |
|
|
| Active, not recruiting | 2b | 357 | Europe, Canada, US, RoW | belapectin, GR-MD-02, galactoarabino rhamnogalacturonate, Placebo | Galectin Therapeutics Inc. | Prevention of Esophageal Varices, NASH - Nonalcoholic Steatohepatitis, Cirrhosis | 12/24 | 12/24 | | |
| Recruiting | 2 | 246 | Europe, Canada, Japan, US, RoW | GSK4532990, Placebo | GlaxoSmithKline | Nonalcoholic Fatty Liver Disease | 09/25 | 12/25 | | |
NCT05687656: Sterilised, Porcine Placental Tissue in the Treatment of Chronic Diabetic Foot Ulcers |
|
|
| Completed | N/A | 30 | US | InnovaMatrix AC porcine placental ECM therapy | ConvaTec Inc. | Diabetic Foot Ulcer | 01/24 | 01/24 | | |
NCT05291169: Omeza Combination Therapy With Standard of Care to Standard of Care Alone for Chronic Venous Leg Ulcers |
|
|
| Completed | N/A | 54 | US | Omeza® OCM™, Omeza® Complete Matrix, Multimodal Wound Matrix | Omeza, LLC | Venous Leg Ulcer | 11/23 | 03/24 | | |
| Completed | N/A | 136 | US | Standard Wound Care Alone, Stand Wound Care plus IPC | Huntleigh Healthcare Ltd, SerenaGroup, Inc. | Venous Leg Ulcer | 03/24 | 03/24 | | |
NCT06606210: INNOVEN: Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Care (SOC) Versus SOC Alone |
|
|
| Recruiting | N/A | 120 | US | InnovaMatrix® AC, Porcine Derived Extracellular Matrix | ConvaTec Inc. | Wound Heal, Venous Leg Ulcer | 07/25 | 04/26 | | |
NCT05923749: A RCT Evaluating the Clinical Benefit of a Silver Dressing in the Treatment of Venous Leg Ulcers |
|
|
| Recruiting | N/A | 178 | Europe, US | Biatain Ag, Cutimed Siltec Sorbact | Coloplast A/S | Wound Heal | 10/24 | 10/24 | | |
Doner, Bryan |
NCT04457752: Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®) |
|
|
| Recruiting | 4 | 124 | US | Dual Layer Amniotic Membrane (DLAM). Artacent® | SerenaGroup, Inc., Tides Medical | Chronic Diabetic Foot Ulcers | 03/22 | 03/23 | | |
Serena, Laura |
| Not yet recruiting | 1 | 40 | NA | NOX1416 plus SOC, ADVANOX, Placebo plus SOC | NOxy Health Products, LLC, SerenaGroup, Inc. | Diabetic Foot Ulcer | 11/25 | 01/26 | | |
DABIRPrU, NCT05033470: A Multicentre Prospective Study Evaluating an Off-loading Mattress Overlay System in Healing of Stage 3 Pressure Ulcers |
|
|
| Recruiting | N/A | 30 | US | Dabir Mattress Overlay System, standard of care | SerenaGroup, Inc., Dabir Surfaces Inc | Pressure Ulcer | 05/23 | 06/23 | | |
NCT05291169: Omeza Combination Therapy With Standard of Care to Standard of Care Alone for Chronic Venous Leg Ulcers |
|
|
| Completed | N/A | 54 | US | Omeza® OCM™, Omeza® Complete Matrix, Multimodal Wound Matrix | Omeza, LLC | Venous Leg Ulcer | 11/23 | 03/24 | | |
NCT05608317: A Clinical Investigation to Follow the Progress of Exuding Chronic Venous Leg Ulcers Using a Non-Bordered Foam Dressing |
|
|
| Recruiting | N/A | 20 | US | ALLEVYN Non-Adhesive | Molnlycke Health Care AB | Wounds, Wound of Skin, Wound Leg, Venous Leg Ulcer | 07/24 | 11/24 | | |
NCT05588583: A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing. |
|
|
| Recruiting | N/A | 68 | US | Mepilex Up | Molnlycke Health Care AB | Wounds, Wound of Skin, Wound Leg, Wound; Foot, Diabetic Foot Ulcer, Venous Leg Ulcer | 03/24 | 03/24 | | |
CAMPAIGN, NCT06600724: Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs |
|
|
| Recruiting | N/A | 170 | US | Standard of Care, EPIEFFECT, EPIXPRESS | MiMedx Group, Inc., SerenaGroup, Inc. | Diabetic Foot Ulcer, Diabetic Foot, Foot Ulcer Due to Type 2 Diabetes Mellitus, Foot Ulcer, Diabetic, Foot Ulcer | 08/26 | 08/26 | | |